Concepedia

Lois La Grenade

LL

Statistics

Publications

12

Citations

836

H-Index

11

Active since

1996

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Harvard Pilgrim Health Care

Harvard University

University of Toronto

Lois La Grenade is an author at Center for Drug Evaluation and Research specializing in medicine, dermatology, and hypersensitivity.

Publications per year

1996–2020

12

Publications

12

Tumor necrosis factor α blockers and malignancy in children: Forty‐eight cases reported to the food and drug administration

Peter Diak, Jeffrey Siegel, Lois La Grenade et al. · Arthritis & Rheumatism · 2010 · 253 citations

, , +15

Clinical, Pathologic, and Immunologic Features of Human T-Lymphotrophic Virus Type I–Associated Infective Dermatitis in Children

Lois La Grenade, Angela Manns, Valerie Fletcher et al. · Archives of Dermatology · 1998 · 160 citations

, , +17

Risk factors for statin‐associated rhabdomyolysis

Stephanie D. Schech, David J. Graham, Judy A. Staffa et al. · Pharmacoepidemiology and Drug Safety · 2006 · 129 citations

, , +11

Comparison of Reporting of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Selective COX-2 Inhibitors

Lois La Grenade, Lauren Lee, Joyce Weaver et al. · Drug Safety · 2005 · 84 citations

, , +10

Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis

Susan E. Andrade, David J. Graham, Judy A. Staffa et al. · Journal of Clinical Epidemiology · 2005 · 44 citations

, , +14

1–5 of 12